MedPath
NMPA Approval

Teicoplanin for Injection

国药准字H20253762

April 1, 2025

Drug Information

注射用替考拉宁

注射剂

0.2g(20万单位)

化学药品

April 1, 2025

Company Information

Applicant Company

山东省烟台市芝罘区烟福路1号

Manufacturing Company

山东省烟台市芝罘区烟福路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用替考拉宁 - NMPA 批准文号 | MedPath